The Proteus Syndrome Treatment Market was valued at USD 0.15 billion in 2024 and is projected to reach USD 0.45 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by several factors, including the increasing awareness of rare genetic disorders, advancements in medical technology, and the rising availability of targeted therapies. The Proteus Syndrome,...